These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28476846)

  • 1. Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer.
    Manig L; Käsmann L; Janssen S; Schild SE; Rades D
    Anticancer Res; 2017 May; 37(5):2693-2696. PubMed ID: 28476846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.
    Mayr R; May M; Martini T; Lodde M; Pycha A; Comploj E; Wieland WF; Denzinger S; Otto W; Burger M; Fritsche HM
    BJU Int; 2012 Sep; 110(6 Pt B):E222-7. PubMed ID: 22314129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.
    Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu FF; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G
    Head Neck; 2016 May; 38(5):736-42. PubMed ID: 25521753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India.
    M SG; Mohapatra PR; Bhuniya S; Das Majumdar SK; Mishra P; Panigrahi MK; Bal SK; Datta A; Venkatachalam P; Chatterjee D
    Cureus; 2022 Oct; 14(10):e30589. PubMed ID: 36420233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists.
    Kim YJ; Hui D; Zhang Y; Park JC; Chisholm G; Williams J; Bruera E
    J Pain Symptom Manage; 2015 Jun; 49(6):1050-1058.e2. PubMed ID: 25542550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
    Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
    J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer.
    Rades D; Manig L; Janssen S; Schild SE
    Anticancer Res; 2017 Mar; 37(3):1481-1484. PubMed ID: 28314321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
    Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
    Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer.
    Rades D; Conde AJ; Garcia R; Cacicedo J; Segedin B; Perpar A; Schild SE
    Radiat Oncol; 2015 Aug; 10():173. PubMed ID: 26282125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
    Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
    Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer.
    Jehn CF; Böning L; Kröning H; Pezzutto A; Lüftner D
    Eur J Cancer; 2014 May; 50(7):1269-75. PubMed ID: 24503027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and functional status are independent in older cancer patients.
    Extermann M; Overcash J; Lyman GH; Parr J; Balducci L
    J Clin Oncol; 1998 Apr; 16(4):1582-7. PubMed ID: 9552069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.
    Chen D; Wen X; Song YS; Rhee YY; Lee TH; Cho NY; Han SW; Kim TY; Kang GH
    Clin Epigenetics; 2016; 8():36. PubMed ID: 27051466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.